Related Experiment Video
Updated: Apr 4, 2026
08:52
Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice
Published on: February 22, 2019
11.5K
[Development of new vaccines].
Fernando González-Romo1, Juan J Picazo1
1Servicio de Microbiología Clínica, Hospital Clínico San Carlos, Facultad de Medicina, Universidad Complutense de Madrid, Madrid, España.
Enfermedades Infecciosas Y Microbiologia Clinica
|September 6, 2015
Summary
Advances in immunology, genomics, and nanotechnology are revolutionizing vaccine development. New approaches enhance immune response and enable lower-cost production for over 130 vaccines targeting diseases like malaria, HIV, and emerging infectious threats.
Area of Science:
- Interdisciplinary research spanning immunology, genomics, bioinformatics, and nanotechnology.
- Integration of diverse scientific fields for novel vaccine strategies.
Background:
- Significant scientific progress has been made in immunology, genomics, and related fields.
- These advances are paving the way for innovative vaccine development.
Purpose of the Study:
- To highlight recent scientific breakthroughs impacting vaccine development.
- To discuss how new technologies are improving vaccine efficacy and accessibility.
Main Methods:
- Leveraging advances in epitope identification and adjuvant technology.
- Exploring novel vaccine administration routes.
- Utilizing multi-omics approaches (genomics, proteomics, metabolomics) and nanotechnology.
Main Results:
- Improved identification of optimal vaccine epitopes.
- Enhanced immune response through novel adjuvants.
- Development of new vaccine administration routes.
- Over 130 vaccines are currently in development for various infectious diseases.
Conclusions:
- Scientific advancements are accelerating vaccine development and production.
- New vaccines are being created for challenging and emerging infectious diseases.
- Future vaccines promise improved efficacy, broader applicability, and lower costs.
Related Concept Videos
01:23Vaccine Production
61
Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...
61
01:51Vaccinations
54.0K
Overview
54.0K
01:22Development of Immunocompetence
1.2K
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
1.2K
01:21Vaccines
49
Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the...
49
01:30Cancer Vaccines
1.3K
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.3K
01:29Microorganisms in Medicine and Therapeutics
1.4K
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
1.4K